drugset / Trial / NCT04639804

Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers

NCT04639804

Phase 1 Completed 60 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to evaluate the pharmacokinetic (PK) interaction between tegoprazan and non-steroidal anti-inflammatory drugs (NSAIDs) after given each alone and in their combination in healthy male adults.

Timeline

Start
2020-06-06
Primary completion
2020-07-26
Completion
2020-07-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aceclofenac Small molecule 100 mg Oral
Comparator Celecoxib Other / unclassified 200 mg Oral
Comparator Naproxen Small molecule 500 mg Oral
Comparator Tegoprazan Other / unclassified 50 mg Oral

Indications

No indication recorded.